Plerixafor for stem cell mobilisation in adults and children

Document first published:: 24 September 2020
Page updated:: 5 October 2020
Topic:: Specialised commissioning
Publication type:: Policy or strategy

The policy is for plerixafor to be available as a treatment option through routine commissioning for autologous haematopoietic stem cell transplant in adults and children within the criteria set out in these documents.

Document

Clinical panel report: Plerixafor for stem cell mobilisation in adults and children - September 2019

Clinical panel report: Plerixafor for stem cell mobilisation in adults and children - September 2019

PDF
71 KB
2 pages

Document

Clinical Commissioning Policy: Plerixafor for stem cell mobilisation in adults and children - July 2019

Clinical Commissioning Policy: Plerixafor for stem cell mobilisation in adults and children - July 2019

PDF
229 KB
14 pages

Document

Evidence review: Plerixafor for stem cell mobilisation in people with haematological tumours (apart from multiple myeloma and lymphoma) or haematological paraneoplastic complications who are receiving autologous haematopoietic stem cell transplantation

Evidence review: Plerixafor for stem cell mobilisation in people with haematological tumours (apart from multiple myeloma and lymphoma) or haematological paraneoplastic complications who are receiving autologous haematopoietic stem cell transplantation

PDF
414 KB
36 pages

Document

Clinical panel report: Plerixafor for stem cell mobilisation in adults and children

Clinical panel report: Plerixafor for stem cell mobilisation in adults and children

PDF
76 KB
2 pages

Document

Evidence review: Plerixafor for stem cell mobilisation in people aged over 24 years with non-haematological solid tumours who are receiving autologous haematopoietic stem cell transplantation

Evidence review: Plerixafor for stem cell mobilisation in people aged over 24 years with non-haematological solid tumours who are receiving autologous haematopoietic stem cell transplantation

PDF
492 KB
42 pages

Document

Clinical priorities advisory group: Plerixafor for stem cell mobilisation in adults and children

Clinical priorities advisory group: Plerixafor for stem cell mobilisation in adults and children

PDF
135 KB
10 pages

Document

Engagement report: Plerixafor for stem cell mobilisation in adults and children

Engagement report: Plerixafor for stem cell mobilisation in adults and children

PDF
118 KB
4 pages

Document

Equality and health inequalities impact assessment: Plerixafor for stem cell mobilisation in adults and children

Equality and health inequalities impact assessment: Plerixafor for stem cell mobilisation in adults and children

PDF
137 KB
10 pages